Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility

BMC Chemical Biology

Volumn 10, Issue , 2010, Pages

  Lavalle, Courtney R ^a   Bravo Altamirano, Karla ^b   Giridhar, Karthik V ^a   Chen, Jun ^a   Sharlow, Elizabeth ^a,b   Lazo, John S ^a,b   Wipf, Peter ^b   Wang, Q Jane ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXY 2,3,4,5 TETRAHYDRO [1]BENZOXOLO[2,3 C]AZEPIN 1 ONE; 9 HYDROXY 1,2,3,4 TETRAHYDROCHROMENO[3,4 B]PYRIDIN 5 ONE; ANTINEOPLASTIC AGENT; CID 755673; CID 797718; KB NB 14270; KB NB 16509; KB NB 16531; KB NB 16592; KB NB 18402; PROTEIN KINASE D INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL ACTIVITY; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MIGRATION INHIBITION; PROSTATE CANCER; STRUCTURE ACTIVITY RELATION;

EID: 77951771770     PISSN: None     EISSN: 14726769     Source Type: Journal    
DOI: 10.1186/1472-6769-10-5     Document Type: Article

References (43)

1. PKCnu, a new member of the protein kinase C family, composes a fourth subfamily with PKCmu. A Hayashi N Seki A Hattori S Kozuma T Saito, Biochim Biophys Acta 1999 1450 1 99 106 10.1016/S0167-4889(99)00040-3 10231560
2. PKCu is a novel, atypical member of the protein kinase C family. FJ Johannes J Prestle S Eis P Oberhagemann K Pfizenmaier, J Biol Chem 1994 269 8 6140 6148 8119958
3. Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. S Sturany J Van Lint F Muller M Wilda H Hameister M Hocker A Brey U Gern J Vandenheede T Gress, et al. J Biol Chem 2001 276 5 3310 3318 10.1074/jbc.M008719200 11062248
4. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. AM Valverde J Sinnett-Smith J Van Lint E Rozengurt, Proc Natl Acad Sci USA 1994 91 18 8572 8576 10.1073/pnas.91.18.8572 8078925
5. The protein kinase complement of the human genome. G Manning DB Whyte R Martinez T Hunter S Sudarsanam, Science 2002 298 5600 1912 1934 10.1126/science.1075762 12471243
6. PKD at the crossroads of DAG and PKC signaling. QJ Wang, Trends Pharmacol Sci 2006 27 6 317 323 10.1016/j.tips.2006.04.003 16678913
7. Protein kinase D activation by mutations within its pleckstrin homology domain. T Iglesias E Rozengurt, J Biol Chem 1998 273 1 410 416 10.1074/jbc.273.1.410 9417097
8. Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. RT Waldron O Rey T Iglesias T Tugal D Cantrell E Rozengurt, J Biol Chem 2001 276 35 32606 32615 10.1074/jbc.M101648200 11410586
9. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. RT Waldron E Rozengurt, J Biol Chem 2003 278 1 154 163 10.1074/jbc.M208075200 12407104
10. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/Protein kinase Cmu. SA Matthews E Rozengurt D Cantrell, J Biol Chem 1999 274 37 26543 26549 10.1074/jbc.274.37.26543 10473617
11. Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: differential regulation of activation loop Ser(744) and Ser(748) phosphorylation. R Jacamo J Sinnett-Smith O Rey RT Waldron E Rozengurt, J Biol Chem 2008 283 19 12877 12887 10.1074/jbc.M800442200 18337243
12. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. C Wong ZG Jin, J Biol Chem 2005 280 39 33262 33269 10.1074/jbc. M503198200 16006559
13. Protein kinase D2 potentiates MEK/ERK/RSK signaling, c-Fos accumulation and DNA synthesis induced by bombesin in Swiss 3T3 cells. J Sinnett-Smith E Zhukova O Rey E Rozengurt, J Cell Physiol 2007 211 3 781 790 10.1002/jcp.20984 17226786
14. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. A Hausser P Storz S Martens G Link A Toker K Pfizenmaier, Nat Cell Biol 2005 7 9 880 886 10.1038/ncb1289 16100512
15. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. C Du M Jaggi C Zhang KC Balaji, Cancer Res 2009 69 3 1117 1124 10.1158/0008-5472.CAN-07-6270 19141652
16. Mitochondrial ROS - radical detoxification, mediated by protein kinase D. P Storz, Trends Cell Biol 2007 17 1 13 18 10.1016/j.tcb.2006.11.003 17126550
17. Class II histone deacetylases: structure, function, and regulation. NR Bertos AH Wang XJ Yang, Biochem Cell Biol 2001 79 3 243 252 10.1139/bcb-79-3-243 11467738
18. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. J Chen F Deng SV Singh QJ Wang, Cancer Res 2008 68 10 3844 3853 10.1158/0008-5472.CAN- 07-5156 18483269
19. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. M Jaggi PS Rao DJ Smith GP Hemstreet KC Balaji, Biochem Biophys Res Commun 2003 307 2 254 260 10.1016/S0006-291X(03)01161-6 12859948 (Pubitemid 36818862)
20. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. ER Sharlow KV Giridhar CR LaValle J Chen S Leimgruber R Barrett K Bravo-Altamirano P Wipf JS Lazo QJ Wang, J Biol Chem 2008 283 48 33516 33526 10.1074/jbc.M805358200 18829454
21. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. G Martiny-Baron MG Kazanietz H Mischak PM Blumberg G Kochs H Hug D Marme C Schachtele, J Biol Chem 1993 268 13 9194 9197 8486620
22. Synthesis of novel S-bridged heterotrinuclear complexes containing six-membered chelate rings: structural, spectroscopic, and electrochemical properties of [Co{Rh(apt)3}2]3+ (apt = 3-aminopropanethiolate). N Amir M Motonishi M Fujita Y Miyashita K Fujisawa K Okamoto, Eur J Inorg Chem 2006 1041 1049 10.1002/ejic.200500701
23. Preparation and testing of tetrazolyl-substituted benzothiophene-2- carboxamides and benzofurancarboxamides as antiallergic agents. DT Connor RJ Sorenson MD Mullican DO Thueson, (Warner-Lambert Co, USA) Eur Pat Appl 1989 20 pp. EP 299457 A2 19890118. Application: EP 88-111224 19880713
24. Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents. DT Connor WA Cetenko MD Mullican RJ Sorenson PC Unangst RJ Weikert RL Adolphson JA Kennedy DO Thueson CD Wright, et al. J Med Chem 1992 35 5 958 965 10.1021/jm00083a023 1372359
25. Design, synthesis, and development of novel caprolactam anticonvulsants. JB Grimm JP Stables ML Brown, Bioorg Med Chem 2003 11 18 4133 4141 10.1016/S0968-0896(03)00400-0 12927875
26. Preparation of Benzothieno[2,3-f]-1,4-oxazepin- and -thiazepin-5(2H)-ones and of Benzothieno[3,2-e]-1,4-diazepin-5-ones. SS Khatana DH Boschelli JB Kramer DT Connor H Barth P Stoss, J Org Chem 1996 61 6060 6062 10.1021/jo960235m (Pubitemid 26287867)
27. a-Oxolactam enamines as new synthons in the Nenitzescu reaction. VM Lyubchanskaya LM Alekseeva SA Savina AS Shashkov VG Granik, Russ Chem Bull, Int Ed 2002 51 1886 1893 10.1023/A:1021308719984 (Pubitemid 37115403)
28. Protein kinase D 3 is localized in vesicular structures and interacts with vesicle-associated membrane protein 2. G Lu J Chen LA Espinoza S Garfield S Toshiyuki H Akiko A Huppler QJ Wang, Cell Signal 2007 19 4 867 879 10.1016/j.cellsig.2006.10.012 17196367
29. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. S Guha O Rey E Rozengurt, Cancer Res 2002 62 6 1632 1640 11912133
30. CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathway. E Torres-Marquez J Sinnett-Smith S Guha R Kui RT Waldron O Rey E Rozengurt, Biochem Biophys Res Commun 391 1 63 68 10.1016/j.bbrc.2009.11.002 19896460
31. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. ET Bowden M Barth D Thomas RI Glazer SC Mueller, Oncogene 1999 18 31 4440 4449 10.1038/sj.onc.1202827 10442635
32. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. M Jaggi PS Rao DJ Smith MJ Wheelock KR Johnson GP Hemstreet KC Balaji, Cancer Res 2005 65 2 483 492 15695390
33. Protein kinase D-mediated anterograde membrane trafficking is required for fibroblast motility. NL Prigozhina CM Waterman-Storer, Curr Biol 2004 14 2 88 98 10.1016/j.cub.2004.01.003 14738729
34. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. JL Zugaza J Sinnett-Smith J Van Lint E Rozengurt, Embo J 1996 15 22 6220 6230 8947045
35. Phosphorylation-dependent protein kinase D activation. RT Waldron T Iglesias E Rozengurt, Electrophoresis 1999 20 2 382 390 10.1002/(SICI)1522- 2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N 10197446
36. PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. A Trauzold S Schmiedel B Sipos H Wermann S Westphal C Roder W Klapper A Arlt L Lehnert H Ungefroren, et al. Oncogene 2003 22 55 8939 8947 10.1038/sj.onc.1207001 14654790
37. Cdk1: the dominant sibling of Cdk2. T Bashir M Pagano, Nat Cell Biol 2005 7 8 779 781 10.1038/ncb0805-779 16056272
38. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. B Hu J Mitra S van den Heuvel GH Enders, Mol Cell Biol 2001 21 8 2755 2766 10.1128/MCB.21.8.2755-2766.2001 11283255
39. p27Kip1 overexpression causes apoptotic death of mammalian cells. X Wang M Gorospe Y Huang NJ Holbrook, Oncogene 1997 15 24 2991 2997 10.1038/sj.onc.1201450 9416843
40. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. A Satyanarayana P Kaldis, Oncogene 2009 28 33 2925 2939 10.1038/onc.2009.170 19561645
41. GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. F Takahashi-Yanaga T Sasaguri, Cell Signal 2008 20 4 581 589 10.1016/j.cellsig.2007.10.018 18023328
42. cAMP-induced degradation of cyclin D3 through association with GSK-3beta. S Naderi KB Gutzkow HU Lahne S Lefdal WJ Ryves AJ Harwood HK Blomhoff, J Cell Sci 2004 117 Pt 17 3769 3783 10.1242/jcs.01210 15252116
43. pRb-dependent cyclin D3 protein stabilization is required for myogenic differentiation. F De Santa S Albini E Mezzaroma L Baron A Felsani M Caruso, Mol Cell Biol 2007 27 20 7248 7265 10.1128/MCB.02199-06 17709384